Here are Thursday's biggest analyst calls: Nvidia, SpaceX, Tesla, Alphabet, Meta, Salesforce, CrowdStrike & more

Wall Street’s biggest calls skew positive: multiple upgrades highlight AI-related demand (e.g., Nvidia raising FY28/CY27 sales growth guidance to ~70% YoY vs ~45% consensus at last read; DigitalOcean initiated as an “AI wave” beneficiary) and favorable growth outlooks (e.g., Synopsys upgraded; Salesforce reiterated as Buy). Offsets include downgrades such as Abercrombie & Fitch to Neutral after a +36% one-day move (only ~6% upside to $156 TP) and Celsius to Hold citing a “challenging road to recovery.” Overall, the flow is mildly supportive for sentiment, but impact is likely more stock-specific than market-wide.

Analysis

The broader signal is a second-order AI spend cycle: not just hyperscaler GPUs, but the plumbing around them. That favors lower-consensus beneficiaries like AMKR and DOCN, plus the software layers that monetize complexity rather than raw compute, where margin leverage can surprise if enterprise AI budgets keep expanding. NVDA remains the cleanest barometer, but the better risk/reward may be in the adjacent suppliers that can re-rate without needing a perfect multiple.

Near term, the market is setting up a classic event-vs-fundamentals split. TSLA has a crowded hype window into the next catalyst, so the stock can trade on narrative before any measurable revenue stream exists; that makes upside fragile if the launch is short on monetization detail. On the consumer side, ANF looks like a valuation reset after a strong run, while CELH and NVO point to execution and product-cycle risk where the first move lower often overshoots, then only stabilizes once channel checks or prescription data improve.

The contrarian miss is duration: the market tends to price "AI winner" labels as if all exposure is equal, but cash conversion and supply-chain leverage matter more than headline growth. AMKR, SNPS, CRWD, and GOOGL have more defensible monetization paths than story stocks, while TSLA's event premium and NVO's long-dated patent issue are both easy to overtrade in the wrong time frame. Falsifiers are simple: a slowdown in hyperscaler capex, weaker 2026 guidance from semiconductor/tooling names, or a post-event TSLA letdown that fails to hold any hype-driven gains.

Key Decisions for Investors

• Go long AMKR on pullbacks for a 6-12 month re-rating trade; the upside is in packaging complexity compounding faster than consensus, and the thesis breaks if AI capex guides down or utilization weakens.
• Sell TSLA into strength ahead of the next event via a short-dated put spread or call spread; base case is hype without near-term monetization, so reward/risk skews to mean reversion if the presentation is light on details.
• Use any post-rally strength in CELH to establish a tactical short or underweight; the recovery path likely needs 1-2 quarters of cleaner execution, so the near-term asymmetry is poor.
• Prefer FSLR over TSLA on a 3-12 month horizon as a cleaner energy-transition pair trade; if solar booking momentum improves, FSLR should re-rate faster than Tesla's solar-threat narrative unwinds.
• Avoid chasing ANF after the move; wait for a pullback or better entry point, since upside from here looks more like a few turns of multiple than a fresh fundamental re-acceleration.